Matching or genetic engineering of HLA Class I and II facilitates successful allogeneic 'off-the-shelf' regulatory T cell therapy (2023)

First Author: McCallion O
Attributed to:  University of Oxford Confidence in Concept – Round 7 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.08.06.551956

Publication URI: http://dx.doi.org/10.1101/2023.08.06.551956

Type: Preprint